Loading clinical trials...
Loading clinical trials...
B Cell Targeted Treatment In Myasthenia Gravis (BeatMG): A Phase II Trial of Rituximab In Myasthenia Gravis
Conditions
Interventions
Rituximab
Placebo
Locations
26
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California - Davis
Davis, California, United States
University of California - Los Angeles
Los Angeles, California, United States
University of Colorado - Denver
Denver, Colorado, United States
Yale School of Medicine, Department of Neurology
New Haven, Connecticut, United States
University of Miami School of Medicine
Miami, Florida, United States
Start Date
May 1, 2014
Primary Completion Date
July 1, 2017
Completion Date
May 1, 2018
Last Updated
March 6, 2020
NCT06312644
NCT06754020
NCT07089121
NCT07246564
NCT07247279
NCT07470151
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions